GTC Biotherapeutics (fka GTCB)

[croumagnon]

"What does this have to do with GTC?"

Nothing whatsoever. This whole thread relating to a possible delisting notice from NASDAQ and moving to the pink sheets is way too premature and not pertinent to where we are. Even if GTCB got a delisting notice, they will have at least 90 days to fix the problem and move the pps past $1, so the pink sheet discussion is way premature especially with US ATryn top line data expected by the end of the month...

On the other hand, the top line data will certainly be a major stock moving event one way or the other. I have generally stopped the practice of taking a large position in a small biotech ahead of a binary event, but I am making an exception with GTCB currently because I think the stock is already priced for bad top line data, and good top line data is very likely and should easily propel us into a double from these prices...